0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Contraceptive Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-22D862
Home | Market Reports | Health| Reproductive Health
Global Oral Contraceptive Drugs Market Insights Forecast to 2028
BUY CHAPTERS

Global Oral Contraceptive Drugs Market Research Report 2025

Code: QYRE-Auto-22D862
Report
September 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Contraceptive Drugs Market Size

The global market for Oral Contraceptive Drugs was valued at US$ 14130 million in the year 2024 and is projected to reach a revised size of US$ 22100 million by 2031, growing at a CAGR of 6.7% during the forecast period.

Oral Contraceptive Drugs Market

Oral Contraceptive Drugs Market

Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation.
The contraceptives market is driven by the increasing awareness and adoption of family planning methods to control population growth and improve maternal and child health. Contraceptives provide individuals with choices for safe and effective birth control, leading to a decline in unintended pregnancies and a healthier reproductive population. Moreover, government initiatives and awareness campaigns aimed at promoting family planning further contribute to market growth. However, challenges include cultural and social barriers, lack of access to contraceptives in certain regions, and potential side effects associated with some contraceptive methods. Addressing these challenges through education, improved access to contraceptives, and the development of innovative and user-friendly contraceptive options will be crucial for sustaining the growth of the contraceptives market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Contraceptive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Contraceptive Drugs.
The Oral Contraceptive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Unit) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Contraceptive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Contraceptive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Contraceptive Drugs Market Report

Report Metric Details
Report Name Oral Contraceptive Drugs Market
Accounted market size in year US$ 14130 million
Forecasted market size in 2031 US$ 22100 million
CAGR 6.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Pharmacy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Contraceptive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Contraceptive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Oral Contraceptive Drugs Market growing?

Ans: The Oral Contraceptive Drugs Market witnessing a CAGR of 6.7% during the forecast period 2025-2031.

What is the Oral Contraceptive Drugs Market size in 2031?

Ans: The Oral Contraceptive Drugs Market size in 2031 will be US$ 22100 million.

Who are the main players in the Oral Contraceptive Drugs Market report?

Ans: The main players in the Oral Contraceptive Drugs Market are Bayer, Pfizer, Teva Pharmaceutical, Merck, Actavis, Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong

What are the Application segmentation covered in the Oral Contraceptive Drugs Market report?

Ans: The Applications covered in the Oral Contraceptive Drugs Market report are Hospital, Pharmacy, Other

What are the Type segmentation covered in the Oral Contraceptive Drugs Market report?

Ans: The Types covered in the Oral Contraceptive Drugs Market report are Long-acting Contraceptives, Short-acting Contraceptives, Emergency Contraceptives

Recommended Reports

Contraceptive Markets

Women's Health Drugs

Oral Medication Markets

1 Oral Contraceptive Drugs Market Overview
1.1 Product Definition
1.2 Oral Contraceptive Drugs by Type
1.2.1 Global Oral Contraceptive Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Long-acting Contraceptives
1.2.3 Short-acting Contraceptives
1.2.4 Emergency Contraceptives
1.3 Oral Contraceptive Drugs by Application
1.3.1 Global Oral Contraceptive Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Oral Contraceptive Drugs Market Size Estimates and Forecasts
1.4.1 Global Oral Contraceptive Drugs Revenue 2020-2031
1.4.2 Global Oral Contraceptive Drugs Sales 2020-2031
1.4.3 Global Oral Contraceptive Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Contraceptive Drugs Market Competition by Manufacturers
2.1 Global Oral Contraceptive Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Contraceptive Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Contraceptive Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Contraceptive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Contraceptive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Contraceptive Drugs, Product Type & Application
2.7 Global Key Manufacturers of Oral Contraceptive Drugs, Date of Enter into This Industry
2.8 Global Oral Contraceptive Drugs Market Competitive Situation and Trends
2.8.1 Global Oral Contraceptive Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Contraceptive Drugs Players Market Share by Revenue
2.8.3 Global Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Contraceptive Drugs Market Scenario by Region
3.1 Global Oral Contraceptive Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Contraceptive Drugs Sales by Region: 2020-2031
3.2.1 Global Oral Contraceptive Drugs Sales by Region: 2020-2025
3.2.2 Global Oral Contraceptive Drugs Sales by Region: 2026-2031
3.3 Global Oral Contraceptive Drugs Revenue by Region: 2020-2031
3.3.1 Global Oral Contraceptive Drugs Revenue by Region: 2020-2025
3.3.2 Global Oral Contraceptive Drugs Revenue by Region: 2026-2031
3.4 North America Oral Contraceptive Drugs Market Facts & Figures by Country
3.4.1 North America Oral Contraceptive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Contraceptive Drugs Sales by Country (2020-2031)
3.4.3 North America Oral Contraceptive Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Contraceptive Drugs Market Facts & Figures by Country
3.5.1 Europe Oral Contraceptive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Contraceptive Drugs Sales by Country (2020-2031)
3.5.3 Europe Oral Contraceptive Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Contraceptive Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Contraceptive Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Contraceptive Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Contraceptive Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Contraceptive Drugs Market Facts & Figures by Country
3.7.1 Latin America Oral Contraceptive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Contraceptive Drugs Sales by Country (2020-2031)
3.7.3 Latin America Oral Contraceptive Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Contraceptive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Contraceptive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Contraceptive Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Contraceptive Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Contraceptive Drugs Sales by Type (2020-2031)
4.1.1 Global Oral Contraceptive Drugs Sales by Type (2020-2025)
4.1.2 Global Oral Contraceptive Drugs Sales by Type (2026-2031)
4.1.3 Global Oral Contraceptive Drugs Sales Market Share by Type (2020-2031)
4.2 Global Oral Contraceptive Drugs Revenue by Type (2020-2031)
4.2.1 Global Oral Contraceptive Drugs Revenue by Type (2020-2025)
4.2.2 Global Oral Contraceptive Drugs Revenue by Type (2026-2031)
4.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Oral Contraceptive Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Contraceptive Drugs Sales by Application (2020-2031)
5.1.1 Global Oral Contraceptive Drugs Sales by Application (2020-2025)
5.1.2 Global Oral Contraceptive Drugs Sales by Application (2026-2031)
5.1.3 Global Oral Contraceptive Drugs Sales Market Share by Application (2020-2031)
5.2 Global Oral Contraceptive Drugs Revenue by Application (2020-2031)
5.2.1 Global Oral Contraceptive Drugs Revenue by Application (2020-2025)
5.2.2 Global Oral Contraceptive Drugs Revenue by Application (2026-2031)
5.2.3 Global Oral Contraceptive Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Oral Contraceptive Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Oral Contraceptive Drugs Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Oral Contraceptive Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Teva Pharmaceutical
6.3.1 Teva Pharmaceutical Company Information
6.3.2 Teva Pharmaceutical Description and Business Overview
6.3.3 Teva Pharmaceutical Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Teva Pharmaceutical Oral Contraceptive Drugs Product Portfolio
6.3.5 Teva Pharmaceutical Recent Developments/Updates
6.4 Merck
6.4.1 Merck Company Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Merck Oral Contraceptive Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Actavis
6.5.1 Actavis Company Information
6.5.2 Actavis Description and Business Overview
6.5.3 Actavis Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Actavis Oral Contraceptive Drugs Product Portfolio
6.5.5 Actavis Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Johnson & Johnson Oral Contraceptive Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Gedeon Richter
6.7.1 Gedeon Richter Company Information
6.7.2 Gedeon Richter Description and Business Overview
6.7.3 Gedeon Richter Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gedeon Richter Oral Contraceptive Drugs Product Portfolio
6.7.5 Gedeon Richter Recent Developments/Updates
6.8 Novo Nordisk A/S
6.8.1 Novo Nordisk A/S Company Information
6.8.2 Novo Nordisk A/S Description and Business Overview
6.8.3 Novo Nordisk A/S Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Novo Nordisk A/S Oral Contraceptive Drugs Product Portfolio
6.8.5 Novo Nordisk A/S Recent Developments/Updates
6.9 ZiZhu
6.9.1 ZiZhu Company Information
6.9.2 ZiZhu Description and Business Overview
6.9.3 ZiZhu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 ZiZhu Oral Contraceptive Drugs Product Portfolio
6.9.5 ZiZhu Recent Developments/Updates
6.10 Baijingyu
6.10.1 Baijingyu Company Information
6.10.2 Baijingyu Description and Business Overview
6.10.3 Baijingyu Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Baijingyu Oral Contraceptive Drugs Product Portfolio
6.10.5 Baijingyu Recent Developments/Updates
6.11 Huazhong
6.11.1 Huazhong Company Information
6.11.2 Huazhong Description and Business Overview
6.11.3 Huazhong Oral Contraceptive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Huazhong Oral Contraceptive Drugs Product Portfolio
6.11.5 Huazhong Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Contraceptive Drugs Industry Chain Analysis
7.2 Oral Contraceptive Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Contraceptive Drugs Production Mode & Process Analysis
7.4 Oral Contraceptive Drugs Sales and Marketing
7.4.1 Oral Contraceptive Drugs Sales Channels
7.4.2 Oral Contraceptive Drugs Distributors
7.5 Oral Contraceptive Drugs Customer Analysis
8 Oral Contraceptive Drugs Market Dynamics
8.1 Oral Contraceptive Drugs Industry Trends
8.2 Oral Contraceptive Drugs Market Drivers
8.3 Oral Contraceptive Drugs Market Challenges
8.4 Oral Contraceptive Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Contraceptive Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Contraceptive Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Contraceptive Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Contraceptive Drugs Sales (K Unit) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Contraceptive Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Contraceptive Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Contraceptive Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Contraceptive Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Contraceptive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Contraceptive Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Contraceptive Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Contraceptive Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Contraceptive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Contraceptive Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Contraceptive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Contraceptive Drugs Sales by Region (2020-2025) & (K Unit)
 Table 18. Global Oral Contraceptive Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Contraceptive Drugs Sales by Region (2026-2031) & (K Unit)
 Table 20. Global Oral Contraceptive Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Contraceptive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Contraceptive Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Contraceptive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Contraceptive Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Contraceptive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Contraceptive Drugs Sales by Country (2020-2025) & (K Unit)
 Table 27. North America Oral Contraceptive Drugs Sales by Country (2026-2031) & (K Unit)
 Table 28. North America Oral Contraceptive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Contraceptive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Contraceptive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Contraceptive Drugs Sales by Country (2020-2025) & (K Unit)
 Table 32. Europe Oral Contraceptive Drugs Sales by Country (2026-2031) & (K Unit)
 Table 33. Europe Oral Contraceptive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Contraceptive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Contraceptive Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Contraceptive Drugs Sales by Region (2020-2025) & (K Unit)
 Table 37. Asia Pacific Oral Contraceptive Drugs Sales by Region (2026-2031) & (K Unit)
 Table 38. Asia Pacific Oral Contraceptive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Contraceptive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Contraceptive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Contraceptive Drugs Sales by Country (2020-2025) & (K Unit)
 Table 42. Latin America Oral Contraceptive Drugs Sales by Country (2026-2031) & (K Unit)
 Table 43. Latin America Oral Contraceptive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Contraceptive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Contraceptive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Contraceptive Drugs Sales by Country (2020-2025) & (K Unit)
 Table 47. Middle East and Africa Oral Contraceptive Drugs Sales by Country (2026-2031) & (K Unit)
 Table 48. Middle East and Africa Oral Contraceptive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Contraceptive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Contraceptive Drugs Sales (K Unit) by Type (2020-2025)
 Table 51. Global Oral Contraceptive Drugs Sales (K Unit) by Type (2026-2031)
 Table 52. Global Oral Contraceptive Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Contraceptive Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Contraceptive Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Contraceptive Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Contraceptive Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Contraceptive Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Contraceptive Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Oral Contraceptive Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Oral Contraceptive Drugs Sales (K Unit) by Application (2020-2025)
 Table 61. Global Oral Contraceptive Drugs Sales (K Unit) by Application (2026-2031)
 Table 62. Global Oral Contraceptive Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Contraceptive Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Contraceptive Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Contraceptive Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Contraceptive Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Contraceptive Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Contraceptive Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Oral Contraceptive Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Bayer Oral Contraceptive Drugs Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Oral Contraceptive Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Teva Pharmaceutical Company Information
 Table 81. Teva Pharmaceutical Description and Business Overview
 Table 82. Teva Pharmaceutical Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Teva Pharmaceutical Oral Contraceptive Drugs Product
 Table 84. Teva Pharmaceutical Recent Developments/Updates
 Table 85. Merck Company Information
 Table 86. Merck Description and Business Overview
 Table 87. Merck Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Merck Oral Contraceptive Drugs Product
 Table 89. Merck Recent Developments/Updates
 Table 90. Actavis Company Information
 Table 91. Actavis Description and Business Overview
 Table 92. Actavis Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Actavis Oral Contraceptive Drugs Product
 Table 94. Actavis Recent Developments/Updates
 Table 95. Johnson & Johnson Company Information
 Table 96. Johnson & Johnson Description and Business Overview
 Table 97. Johnson & Johnson Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Johnson & Johnson Oral Contraceptive Drugs Product
 Table 99. Johnson & Johnson Recent Developments/Updates
 Table 100. Gedeon Richter Company Information
 Table 101. Gedeon Richter Description and Business Overview
 Table 102. Gedeon Richter Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Gedeon Richter Oral Contraceptive Drugs Product
 Table 104. Gedeon Richter Recent Developments/Updates
 Table 105. Novo Nordisk A/S Company Information
 Table 106. Novo Nordisk A/S Description and Business Overview
 Table 107. Novo Nordisk A/S Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Novo Nordisk A/S Oral Contraceptive Drugs Product
 Table 109. Novo Nordisk A/S Recent Developments/Updates
 Table 110. ZiZhu Company Information
 Table 111. ZiZhu Description and Business Overview
 Table 112. ZiZhu Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. ZiZhu Oral Contraceptive Drugs Product
 Table 114. ZiZhu Recent Developments/Updates
 Table 115. Baijingyu Company Information
 Table 116. Baijingyu Description and Business Overview
 Table 117. Baijingyu Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Baijingyu Oral Contraceptive Drugs Product
 Table 119. Baijingyu Recent Developments/Updates
 Table 120. Huazhong Company Information
 Table 121. Huazhong Description and Business Overview
 Table 122. Huazhong Oral Contraceptive Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Huazhong Oral Contraceptive Drugs Product
 Table 124. Huazhong Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Oral Contraceptive Drugs Distributors List
 Table 128. Oral Contraceptive Drugs Customers List
 Table 129. Oral Contraceptive Drugs Market Trends
 Table 130. Oral Contraceptive Drugs Market Drivers
 Table 131. Oral Contraceptive Drugs Market Challenges
 Table 132. Oral Contraceptive Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Contraceptive Drugs
 Figure 2. Global Oral Contraceptive Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Contraceptive Drugs Market Share by Type: 2024 & 2031
 Figure 4. Long-acting Contraceptives Product Picture
 Figure 5. Short-acting Contraceptives Product Picture
 Figure 6. Emergency Contraceptives Product Picture
 Figure 7. Global Oral Contraceptive Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Oral Contraceptive Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Pharmacy
 Figure 11. Other
 Figure 12. Global Oral Contraceptive Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Oral Contraceptive Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Oral Contraceptive Drugs Sales (2020-2031) & (K Unit)
 Figure 15. Global Oral Contraceptive Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 16. Oral Contraceptive Drugs Report Years Considered
 Figure 17. Oral Contraceptive Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Oral Contraceptive Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Oral Contraceptive Drugs Players: Market Share by Revenue in Oral Contraceptive Drugs in 2024
 Figure 20. Oral Contraceptive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Oral Contraceptive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Oral Contraceptive Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Oral Contraceptive Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Oral Contraceptive Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Oral Contraceptive Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Oral Contraceptive Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Oral Contraceptive Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Oral Contraceptive Drugs Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Oral Contraceptive Drugs Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Oral Contraceptive Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Oral Contraceptive Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. U.A.E Oral Contraceptive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Oral Contraceptive Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Oral Contraceptive Drugs by Type (2020-2031)
 Figure 57. Global Oral Contraceptive Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Oral Contraceptive Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Oral Contraceptive Drugs by Application (2020-2031)
 Figure 60. Global Oral Contraceptive Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 61. Oral Contraceptive Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Tadalafil Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12D16691
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ganirelix Acetate Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B16887
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Single Use Uterine Manipulator Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15L16691
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Assisted Reproductive Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10C16781
Thu Sep 25 00:00:00 UTC 2025

Add to Cart